Vanguard Capital Wealth Advisors Arrowhead Pharmaceuticals, Inc. Transaction History

Vanguard Capital Wealth Advisors

$102 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	BUY	$25.16 - $41.38 $154,356 - $253,866	6,135 New	6,135 $218,000
Q4 2022 Jan 17, 2023	SELL	$28.0 - $40.56 $39,200 - $56,784	-1,400 Reduced 15.85%	7,435 $0
Q3 2022 Oct 21, 2022	SELL	$29.63 - $48.31 $8,889 - $14,493	-300 Reduced 3.28%	8,835 $292,000
Q2 2022 Aug 04, 2022	SELL	$27.79 - $50.61 $2,779 - $5,061	-100 Reduced 1.08%	9,135 $321,000
Q1 2022 Apr 29, 2022	SELL	$39.62 - $69.97 $32,250 - $56,955	-814 Reduced 8.1%	9,235 $424,000
Q4 2021 Feb 02, 2022	SELL	$58.09 - $82.51 $49,376 - $70,133	-850 Reduced 7.8%	10,049 $666,000
Q3 2021 Nov 01, 2021	BUY	$58.38 - $84.96 $5,838 - $8,496	100 Added 0.93%	10,899 $680,000
Q2 2021 Jul 28, 2021	SELL	$62.15 - $90.32 $18,645 - $27,095	-300 Reduced 2.7%	10,799 $894,000
Q1 2021 Apr 12, 2021	SELL	$61.35 - $90.47 $70,552 - $104,040	-1,150 Reduced 9.39%	11,099 $735,000
Q4 2020 Jan 25, 2021	SELL	$43.82 - $85.37 $74,494 - $145,129	-1,700 Reduced 12.19%	12,249 $948,000
Q2 2020 Aug 05, 2020	SELL	$26.12 - $43.27 $155,022 - $256,807	-5,935 Reduced 29.85%	13,949 $602,000
Q4 2019 Jan 28, 2020	SELL	$28.14 - $73.01 $55,576 - $144,194	-1,975 Reduced 9.04%	19,884 $1.26 Million
Q3 2019 Oct 18, 2019	SELL	$26.26 - $34.86 $44,642 - $59,262	-1,700 Reduced 7.22%	21,859 $615,000
Q2 2019 Aug 05, 2019	SELL	$17.43 - $28.82 $35,295 - $58,360	-2,025 Reduced 7.92%	23,559 $624,000
Q4 2018 Jan 17, 2019	SELL	$10.74 - $19.7 $10,740 - $19,700	-1,000 Reduced 3.76%	25,584 $317,000
Q3 2018 Oct 19, 2018	SELL	$14.0 - $20.3 $51,800 - $75,110	-3,700 Reduced 12.22%	26,584 $509,000
Q2 2018 Aug 15, 2018	SELL	$6.37 - $14.02 $9,555 - $21,030	-1,500 Reduced 4.72%	30,284 $411,000
Q1 2018 Apr 25, 2018	SELL	$3.72 - $7.64 $1,860 - $3,820	-500 Reduced 1.55%	31,784 $0
Q4 2017 Feb 15, 2018	BUY	$3.14 - $4.5 $101,371 - $145,278	32,284	32,284 $0

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.5M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Capital Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Capital Wealth Advisors with notifications on news.

Account